EE04114B1 - HIV-proteaasi inhibiitorid - Google Patents

HIV-proteaasi inhibiitorid

Info

Publication number
EE04114B1
EE04114B1 EEP199900416A EEP9900416A EE04114B1 EE 04114 B1 EE04114 B1 EE 04114B1 EE P199900416 A EEP199900416 A EE P199900416A EE P9900416 A EEP9900416 A EE P9900416A EE 04114 B1 EE04114 B1 EE 04114B1
Authority
EE
Estonia
Prior art keywords
protease inhibitors
hiv protease
hiv
inhibitors
protease
Prior art date
Application number
EEP199900416A
Other languages
English (en)
Estonian (et)
Inventor
F. Albizati Kim
Heinz Reich Siegfried
D. Varney Michael
E. Zhang Kanyin
Kobayashi Takuo
Original Assignee
Agouron Pharmaceuticals, Inc.
Japan Tobacco Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agouron Pharmaceuticals, Inc., Japan Tobacco Inc. filed Critical Agouron Pharmaceuticals, Inc.
Publication of EE9900416A publication Critical patent/EE9900416A/xx
Publication of EE04114B1 publication Critical patent/EE04114B1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/472Non-condensed isoquinolines, e.g. papaverine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/22Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/14Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/36Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D335/00Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/02Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
EEP199900416A 1997-03-13 1998-03-12 HIV-proteaasi inhibiitorid EE04114B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81595197A 1997-03-13 1997-03-13
PCT/US1998/004735 WO1998040357A2 (en) 1997-03-13 1998-03-12 Hiv protease inhibitors

Publications (2)

Publication Number Publication Date
EE9900416A EE9900416A (et) 2000-04-17
EE04114B1 true EE04114B1 (et) 2003-08-15

Family

ID=25219265

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP199900416A EE04114B1 (et) 1997-03-13 1998-03-12 HIV-proteaasi inhibiitorid

Country Status (35)

Country Link
EP (1) EP0970055A2 (uk)
JP (1) JP2001516350A (uk)
KR (1) KR100511089B1 (uk)
CN (1) CN1179948C (uk)
AP (1) AP1358A (uk)
AR (1) AR012556A1 (uk)
AU (1) AU743078B2 (uk)
BG (1) BG63540B1 (uk)
BR (1) BR9808867A (uk)
CA (1) CA2284163A1 (uk)
CO (1) CO4940496A1 (uk)
CZ (1) CZ296647B6 (uk)
EA (1) EA002378B1 (uk)
EE (1) EE04114B1 (uk)
GE (1) GEP20022764B (uk)
HR (1) HRP980112A2 (uk)
HU (1) HUP0001380A3 (uk)
IL (2) IL131870A0 (uk)
IS (1) IS5176A (uk)
MX (1) MXPA99008395A (uk)
MY (1) MY117535A (uk)
NO (1) NO315555B1 (uk)
NZ (1) NZ337706A (uk)
OA (1) OA11196A (uk)
PA (1) PA8448801A1 (uk)
PE (1) PE58799A1 (uk)
PL (1) PL192786B1 (uk)
SA (1) SA98181116B1 (uk)
SK (1) SK283636B6 (uk)
SV (1) SV1998000038A (uk)
TR (1) TR199902508T2 (uk)
TW (1) TW200517112A (uk)
UA (1) UA57772C2 (uk)
WO (1) WO1998040357A2 (uk)
ZA (1) ZA982047B (uk)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5484926A (en) * 1993-10-07 1996-01-16 Agouron Pharmaceuticals, Inc. HIV protease inhibitors

Also Published As

Publication number Publication date
SV1998000038A (es) 1999-02-15
MY117535A (en) 2004-07-31
IL131870A0 (en) 2001-03-19
CN1253548A (zh) 2000-05-17
NO994415D0 (no) 1999-09-10
ZA982047B (en) 1998-09-28
HUP0001380A3 (en) 2001-12-28
TR199902508T2 (xx) 2000-02-21
SK283636B6 (sk) 2003-11-04
CZ319199A3 (cs) 2000-06-14
HUP0001380A2 (hu) 2000-09-28
IS5176A (is) 1999-09-10
CN1179948C (zh) 2004-12-15
SA98181116B1 (ar) 2006-10-04
EA002378B1 (ru) 2002-04-25
BG103727A (en) 2000-04-28
KR100511089B1 (ko) 2005-08-31
AU6457598A (en) 1998-09-29
WO1998040357A3 (en) 1998-11-26
PA8448801A1 (es) 2000-05-24
CO4940496A1 (es) 2000-07-24
MXPA99008395A (es) 2003-08-12
NO315555B1 (no) 2003-09-22
KR20000076236A (ko) 2000-12-26
SK122299A3 (en) 2000-05-16
PL192786B1 (pl) 2006-12-29
BR9808867A (pt) 2000-07-11
PL335672A1 (en) 2000-05-08
EP0970055A2 (en) 2000-01-12
AP9901648A0 (en) 1999-09-30
AU743078B2 (en) 2002-01-17
PE58799A1 (es) 1999-07-12
HRP980112A2 (en) 1998-12-31
AR012556A1 (es) 2000-11-08
UA57772C2 (uk) 2003-07-15
EA199900823A1 (ru) 2000-04-24
TW200517112A (en) 2005-06-01
JP2001516350A (ja) 2001-09-25
CZ296647B6 (cs) 2006-05-17
BG63540B1 (bg) 2002-04-30
AP1358A (en) 2004-12-03
CA2284163A1 (en) 1998-09-17
NZ337706A (en) 2001-04-27
WO1998040357A2 (en) 1998-09-17
IL131870A (en) 2006-04-10
NO994415L (no) 1999-11-10
OA11196A (en) 2003-05-21
EE9900416A (et) 2000-04-17
GEP20022764B (en) 2002-08-26

Similar Documents

Publication Publication Date Title
NO995433D0 (no) Protease-inhibitorer
ATE362918T1 (de) Hiv protease inhibitoren
NO20012980D0 (no) Proteaseinhibitorer
DE69823178D1 (de) Serine protease inhibitoren
ID25897A (id) Variant-variant protease tersubstitusi banyak
PT936912E (pt) Inibidores de cisteina protease
NO996578D0 (no) Urokinase-inhibitorer
DK0958287T3 (da) Sulfamidmetalloprotease-inhibitorer
NO995434D0 (no) Proteaseinhibitorer
NO995435D0 (no) Protease-inhibitorer
NO995268D0 (no) Proteaseinhibitorer
ZA984514B (en) Hiv protease inhibitor
IL132998A0 (en) Vif-derived hiv protease inhibitors
EE9900416A (et) HIV-proteaasi inhibiitorid
MA26429A1 (fr) Inhibiteurs de protease
GB9714320D0 (en) Hiv protease inhibitor

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20091231

MM4A Lapsed by not paying the annual fees

Effective date: 20100312